TY - JOUR T1 - Landscape Analysis of Phase 2 and 3 Clinical Trials for Targeted Radionuclide Therapy JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1031 LP - 1032 DO - 10.2967/jnumed.120.258103 VL - 62 IS - 8 AU - Erik Mittra AU - Lisa Bodei Y1 - 2021/08/01 UR - http://jnm.snmjournals.org/content/62/8/1031.abstract N2 - ER -